Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
158.73
-4.33 (-2.66%)
At close: Apr 28, 2026, 4:00 PM EDT
159.33
+0.60 (0.38%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Belite Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 38.83 | 10.06 | 6.82 | 3.95 | 2.38 | |
| Research & Development | 45.38 | 29.94 | 24.84 | 8.87 | 7.42 | |
| Operating Expenses | 84.21 | 40 | 31.67 | 12.82 | 9.8 | |
| Operating Income | -84.21 | -40 | -31.67 | -12.82 | -9.8 | |
| Interest Expense | -0 | -0.02 | -0.03 | -0.02 | - | |
| Interest & Investment Income | 6.64 | 3.74 | 0.07 | 0.02 | 0.01 | |
| Currency Exchange Gain (Loss) | - | - | - | 0.17 | - | |
| Other Non Operating Income (Expenses) | -0.04 | 0.14 | -0 | - | 0.13 | |
| Pretax Income | -77.61 | -36.14 | -31.62 | -12.65 | -9.67 | |
| Income Tax Expense | - | 0.01 | 0.01 | - | - | |
| Net Income | -77.61 | -36.14 | -31.63 | -12.65 | -9.67 | |
| Net Income to Common | -77.61 | -36.14 | -31.63 | -12.65 | -9.67 | |
| Shares Outstanding (Basic) | 34 | 31 | 27 | 20 | 10 | |
| Shares Outstanding (Diluted) | 34 | 31 | 27 | 20 | 10 | |
| Shares Change (YoY) | 9.82% | 14.83% | 33.12% | 108.74% | 8.87% | |
| EPS (Basic) | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 | |
| EPS (Diluted) | -2.31 | -1.18 | -1.19 | -0.63 | -1.01 | |
| Free Cash Flow | -37.17 | -29.35 | -29.9 | -11.85 | -7.55 | |
| Free Cash Flow Per Share | -1.11 | -0.96 | -1.12 | -0.59 | -0.79 | |
| EBITDA | -84.02 | -39.83 | -31.53 | -12.76 | -9.77 | |
| D&A For EBITDA | 0.18 | 0.17 | 0.14 | 0.06 | 0.03 | |
| EBIT | -84.21 | -40 | -31.67 | -12.82 | -9.8 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.